Reckitt Benckiser (RB) Downgraded by Credit Suisse Group

Credit Suisse Group cut shares of Reckitt Benckiser (LON:RB) to an underperform rating in a research note released on Friday morning.

Several other equities analysts have also weighed in on RB. Kepler Capital Markets dropped their price objective on shares of Reckitt Benckiser from GBX 7,300 ($99.02) to GBX 7,000 ($94.95) and set a hold rating on the stock in a report on Monday, January 8th. Morgan Stanley set a GBX 9,000 ($122.08) price objective on shares of Reckitt Benckiser and gave the company a buy rating in a report on Tuesday, January 9th. JPMorgan Chase reiterated an overweight rating and set a GBX 7,500 ($101.74) price objective on shares of Reckitt Benckiser in a report on Wednesday, January 10th. UBS set a GBX 7,000 ($94.95) price objective on shares of Reckitt Benckiser and gave the company a neutral rating in a report on Thursday, January 11th. Finally, Liberum Capital reiterated a buy rating and set a GBX 8,000 ($108.52) price objective on shares of Reckitt Benckiser in a report on Monday, January 15th. Three equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and eleven have given a buy rating to the company’s stock. Reckitt Benckiser has a consensus rating of Hold and a consensus target price of GBX 7,097.39 ($96.27).

Shares of RB opened at GBX 5,727 ($77.69) on Friday. Reckitt Benckiser has a 12 month low of GBX 5,562 ($75.45) and a 12 month high of GBX 8,110.43 ($110.02).

The company also recently disclosed a dividend, which will be paid on Thursday, May 24th. Shareholders of record on Thursday, April 12th will be paid a GBX 97.70 ($1.33) dividend. This is a positive change from Reckitt Benckiser’s previous dividend of $66.60. The ex-dividend date of this dividend is Thursday, April 12th. This represents a yield of 1.65%.

Reckitt Benckiser Company Profile

Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers products for the treatment of analgesic and gastro-intestinal problems, sore throat, cough, pain, and flu, as well as wellness products in sexual wellbeing, footcare, vitamins, and supplements under the Durex, Gaviscon, Nurofen, Mucinex, Scholl/Amopé, and Strepsils brand names.

Analyst Recommendations for Reckitt Benckiser (LON:RB)

Receive News & Ratings for Reckitt Benckiser Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser and related companies with MarketBeat.com's FREE daily email newsletter.




Leave a Reply